Morniflumate

Morniflumate

Systematic (IUPAC) name
2-morpholin-4-ylethyl 2-{[3-(trifluoromethyl)phenyl]amino}nicotinate
Clinical data
AHFS/Drugs.com	International Drug Names
Identifiers
CAS Number	65847-85-0
ATC code	M01AX22 (WHO)
PubChem	CID 72106
ChemSpider	65089
UNII	R133MWH7X1
KEGG	D05078
Chemical data
Formula	C19H20F3N3O3
Molar mass	395.37561 g/mol
SMILES FC(F)(F)c1cc(ccc1)Nc2ncccc2C(=O)OCCN3CCOCC3
InChI InChI=1S/C19H20F3N3O3/c20-19(21,22)14-3-1-4-15(13-14)24-17-16(5-2-6-23-17)18(26)28-12-9-25-7-10-27-11-8-25/h1-6,13H,7-12H2,(H,23,24) Key:LDXSPUSKBDTEKA-UHFFFAOYSA-N
(verify)

Morniflumate is a non-steroidal anti-inflammatory drug.^[1][2][3]

References

1. Melica, A.; Donateo, L.; Gerardi, R.; Parenti, M. (1991). "A new anti-inflammatory-analgesic-antipyretic, morniflumate, in the treatment of chronic recurring bronchitis". Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques 13 (1–2): 51–60. PMID 1796197.
2. Civelli, M.; Vigano, T.; Acerbi, D.; Caruso, P.; Giossi, M.; Bongrani, S.; Folco, G. C. (1991). "Modulation of arachidonic acid metabolism by orally administered morniflumate in man". Agents and actions 33 (3–4): 233–239. doi:10.1007/bf01986568. PMID 1659152.
3. Schiantarelli, P.; Cadel, S.; Acerbi, D. (1984). "A gastroprotective anti-inflammatory agent: Theβ-morpholinoethyl ester of niflumic acid (morniflumate)". Agents and Actions 14 (2): 247–256. doi:10.1007/BF01966649. PMID 6608862.